The effect of high outflow permeability in asymmetric poly(DL-lactic acid-co-glycolic acid) conduits for peripheral nerve regeneration

被引:87
作者
Chang, CJ
Hsu, SH [1 ]
机构
[1] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan
[2] Chung Tai Inst Hlth Sci & Technol, Dept Radiol Technol, Taichung, Taiwan
关键词
poly(DL-lactic acid-co-glycolic acid); asymmetric conduit; nerve regeneration; immersion-precipitation; phase inversion;
D O I
10.1016/j.biomaterials.2005.07.003
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study attempted to accelerate the peripheral nerve regeneration, using the high Outflow rate of asymmetric poly(DL-lactic acid-co-glycolic acid) (PLGA) nerve conduits. Asymmetric PLGA nerve conduits of monomer ratio 85/15 were prepared by immersion-precipitation method to serve as possible materials. In this study, mandrels were immersed into a 20% (wt/wt) of PLGA/1,4-dioxane solution and precipitated in a non-solvent bath followed by freeze-drying. Different concentrations of isopropyl alcohol (95%, 40% and 20%) were used as precipitation baths where non-asymmetric (95%) and asymmetric (40% and 20%) conduits could easily form. The asymmetric nerve conduits that consisted of macrovoids on the outer layer, and interconnected micropores in the inner sublayer, possessed characters of larger outflow rate than inflow rate. The asymmetric conduits were implanted to 10 mm right sciatic nerve defects in rats. Autografts, silicone and non-asymmetric PLGA conduits were performed as the control and the contrast groups. Implanted graft specimens of all groups were harvested for histological analysis at 4 and 6 weeks following Surgery. The asymmetric PLGA conduits maintained a stable supporting structure and inhibited exogenous cells invasion during entire regeneration process. Asymmetric PLGA conduits were found to have statistically greater number of regenerated axons at the midconduit and distal nerve site of implanted grafts, as compared to the silicone and non-asymmetric groups at 4 and 6 weeks. Of interest was that the results of 4 weeks in asymmetric groups were better than the non-asymmetric groups at 6 weeks in number of axons. According to the results of permeability, the asymmetric structure in the conduit wall seemed to enhance the removal of the blockage of the waste drain from the inner inflamed wound in the early stage, which may have improved the efficacy of the peripheral nerve regeneration. The asymmetric structure could be adequately employed in the future as optimal nerve conduits in peripheral nerve regeneration. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1035 / 1042
页数:8
相关论文
共 29 条
[1]  
AEBISCHER P, 1989, J NEUROSCI, V9, P3590
[2]   Effectiveness of a bioabsorbable conduit in the repair of peripheral nerve [J].
Aldini, NN ;
Perego, G ;
Cella, GD ;
Maltarello, MC ;
Fini, M ;
Rocca, M ;
Giardino, R .
BIOMATERIALS, 1996, 17 (10) :959-962
[3]   A COLLAGEN-BASED NERVE GUIDE CONDUIT FOR PERIPHERAL-NERVE REPAIR - AN ELECTROPHYSIOLOGICAL STUDY OF NERVE REGENERATION IN RODENTS AND NONHUMAN-PRIMATES [J].
ARCHIBALD, SJ ;
KRARUP, C ;
SHEFNER, J ;
LI, ST ;
MADISON, RD .
JOURNAL OF COMPARATIVE NEUROLOGY, 1991, 306 (04) :685-696
[4]   FK506 and cyclosporin a enhance the survival of cultured and grafted rat embryonic dopamine neurons [J].
Castilho, RF ;
Hansson, O ;
Brundin, P .
EXPERIMENTAL NEUROLOGY, 2000, 164 (01) :94-101
[5]   A NEW PLLA PCL COPOLYMER FOR NERVE REGENERATION [J].
DENDUNNEN, WFA ;
SCHAKENRAAD, JM ;
ZONDERVAN, GJ ;
PENNINGS, AJ ;
VANDERLEI, B ;
ROBINSON, PH .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1993, 4 (05) :521-525
[6]  
DOUGLAS WZ, 2000, MUSCLE NERVE S, V9, pS33
[7]   The development of bioartificial nerve grafts for peripheral-nerve regeneration [J].
Heath, CA ;
Rutkowski, GE .
TRENDS IN BIOTECHNOLOGY, 1998, 16 (04) :163-168
[8]   FABRICATION AND CHARACTERIZATION OF AN ASYMMETRIC POLYURETHANE MEMBRANE FOR USE AS A WOUND DRESSING [J].
HINRICHS, WLJ ;
LOMMEN, EJCMP ;
WILDEVUUR, CRH ;
FEIJEN, J .
JOURNAL OF APPLIED BIOMATERIALS, 1992, 3 (04) :287-303
[9]  
HOLZER P, 1991, PHARMACOL REV, V43, P143